News
-
-
PRESS RELEASE
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converted 4 convertible bonds in Oxurion, leading to a EUR 100,000 capital increase. Oxurion focuses on developing vision-preserving therapeutics for the elderly -
-
-
-
-
-
PRESS RELEASE
Oxurion Announces Postponement of Signing for Strategic Transaction Due to Ongoing Discussions
Oxurion NV announces a short postponement of approximately four weeks for the signing of its strategic transaction due to better than expected financial results of the target. Parties are committed to finalizing the agreement as a key priority